The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.
about
Imaging of coronary atherosclerosis in various susceptible groupsUse of fibrates in the metabolic syndrome: A reviewMetabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcomeMetabolic syndrome in rheumatoid arthritisMonounsaturated fatty acids and risk of cardiovascular disease: synopsis of the evidence available from systematic reviews and meta-analysesThe prevalence of carotid plaque with different stability and its association with metabolic syndrome in China: The Asymptomatic Polyvascular Abnormalities Community study.An essential role for diet in exercise-mediated protection against dyslipidemia, inflammation and atherosclerosis in ApoE⁻/⁻ mice.Fetal programming and metabolic syndrome.Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.Fructose impairs glucose-induced hepatic triglyceride synthesis.Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis.Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy.Impact of targeted specific antibiotic delivery for gut microbiota modulation on high-fructose-fed rats.Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the Manchester children's growth and vascular health study.Is metabolic syndrome predictive of prevalence, extent, and risk of coronary artery disease beyond its components? Results from the multinational coronary CT angiography evaluation for clinical outcome: an international multicenter registry (CONFIRMMitigating preventable chronic disease: Progress report of the Cleveland Clinic's Lifestyle 180 programEstrogen and n-3 polyunsaturated fatty acid supplementation have a synergistic hypotriglyceridemic effect in ovariectomized ratsSocioeconomic disparities and smoking habits in metabolic syndrome: evidence from isfahan healthy heart program.Gender difference in components of metabolic syndrome among patients of type 2 diabetes.Metabolic syndrome in central Brazil: prevalence and correlates in the adult population.Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study.The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trialAssociation between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study.Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapyA meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsMolecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.Adropin- A Novel Biomarker of Heart Disease: A Systematic Review ArticleEffect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery DiseaseEffects of monounsaturated fatty acids on cardiovascular risk factors: a systematic review and meta-analysis.The emerging role of plasma lipidomics in cardiovascular drug discovery.Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability.Obesity and Clinical Riskiness Relationship: Therapeutic Management by Dietary Antioxidant Supplementation--a Review.Components of the metabolic syndrome and depressive symptoms in community-dwelling older people: the Bambuí Cohort Aging Study.Treatment benefits on metabolic syndrome with diet and physical activitySelf-Reported Adherence among Individuals at High Risk of Metabolic Syndrome: Effect of Knowledge and Attitude.Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis.Association between metabolic syndrome and white matter lesions in middle-aged and elderly patients.Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome.
P2860
Q26738569-779CDED7-DDDD-4540-82DF-D7116EF1CC63Q26765234-03F2962A-455E-4B93-9E38-63F078A24F87Q26799612-817BCFED-D283-48F3-AD4C-299813B7B28FQ26822038-C3DA0CA9-4FCD-4E97-BBF3-4B9D68091B9FQ26998824-A3B8FA14-A87F-473B-BCED-15BCC70385B5Q33590556-1F9885D9-48AF-4319-9C97-F95732FF5E10Q33831999-7418DF56-5CB3-4CF8-A941-2ED463D199E6Q34041888-0E6812DB-17C2-4ACE-B423-7895B0EA4F56Q34224453-8B7CA54B-6963-4CCB-986A-7747A028B066Q34386877-2848685E-C224-4101-8C6C-FBA736B81B93Q34547331-F40FAB0D-6414-4BC6-8FBE-4841F00DB44CQ34729697-944391A1-3AA2-41E6-BC8B-391535C997CFQ34788837-F11A5D43-38DA-4A8D-8327-CA61E781A4DBQ35103651-AAD4B4AB-F587-400D-BB05-227717747D92Q35137188-77210916-C9F8-46D7-981C-CB0EA62F9137Q35143798-41B71640-1E17-47C4-9B47-7C9A73343A51Q35690086-6BA69E4B-244A-4324-9F97-C0D1C1809440Q35779693-D7183F27-4087-4B5D-9C5A-8CF988A4E1D6Q36022508-C400D6B0-114B-467D-930B-8CBEA5126F9DQ36110978-C1410C07-A35B-4BEE-807B-1652987E00BCQ36278511-18B8C79F-6AB1-49E4-9E0D-C5F137B22653Q36541754-7BCED308-B0F5-4E90-BF04-5ED869BC72FDQ36842540-5FC13713-7E7F-462F-ADEF-CC9A02FC69D3Q37130582-CC827984-A23B-407B-992A-E3FFBD1D192CQ37151954-07424DC0-F238-4742-A1A7-BDBBF4251DB4Q37155953-682B596D-2DA2-4D97-A015-1DD05EBC929AQ37236162-048D908B-A43A-4FEB-B8E3-39E419A994E1Q37254899-51A3ED71-3798-4B0F-8F5D-EF54F0B1E0B0Q37551314-08149A85-2691-441F-BAEE-E02096A3F7FCQ37711655-D59DF325-7BC1-4CD5-9D4E-269C4F80A65AQ37964884-32684620-A96B-484C-AC24-A4D82F284556Q37999089-FBF089E4-857C-4FD9-A0BE-5D564C720481Q38263804-3F504808-521D-48F6-8BA7-4DC5F479EAE3Q38416364-20BD485C-28AD-484B-BE9C-FF7A60BE8A78Q39504880-DCA27CAB-9A0F-4685-BA0A-F21799F1326CQ41008140-FCE63306-3455-476D-B6BD-10585EA5B2DCQ42756312-2CE9E948-1295-461B-A22D-11E71DDD4B5DQ44655760-18D78FAB-9CB8-4B28-B656-FC646E7470F2Q45029098-15D2E256-4CC4-4810-B5A6-FF733F647ADFQ51245649-217A191D-9F76-4024-BC77-792DAEAA2216
P2860
The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@en
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@nl
type
label
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@en
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@nl
prefLabel
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@en
The metabolic syndrome, its co ...... n of coronary atherosclerosis.
@nl
P2093
P1476
The metabolic syndrome, its co ...... on of coronary atherosclerosis
@en
P2093
Andrea Lavoie
E Murat Tuzcu
Kathy Wolski
Ozgur Bayturan
Samir Kapadia
Steven E Nissen
Tingfei Hu
P304
P356
10.1001/ARCHINTERNMED.2009.551
P407
P577
2010-03-01T00:00:00Z